Are you a healthcare professional looking for highly portable, up-to-date information on drugs used to treat cardiovascular disease? Look no further. Drugs for the Heart is the ultimate reference guide that provides all the information you need to make effective clinical decisions on behalf of your patients.

Written by Drs. Lionel H. Opie and Bernard J. Gersh, this book covers the latest dosages, interactions, indications, contraindications, side effects, and more for every drug class used in the treatment of cardiovascular disease. With this comprehensive guide, you can quickly access information on when to use each drug for any condition, making it an invaluable resource for any healthcare professional.

One of the standout features of this book is the “Which Drug for Which Disease” chapter, which allows you to easily check which drug to use for a specific condition. This saves you time and helps ensure that you are providing the best possible treatment for your patients.

The editors, Drs. Opie and Gersh, bring their practice-proven experience and expertise in cardiovascular therapeutics to this book, making it a reliable and trusted resource. Their combination of clinical and research expertise ensures that you are getting the most up-to-date and evidence-based information.

Not only is Drugs for the Heart packed with essential information, but it is also highly portable. The pocket-sized format allows you to carry it with you anywhere, making it convenient for quick reference on the go.

In this latest edition, you will find coverage of the newest drugs and drug classes, as well as the latest clinical trial results and evidence used to treat heart disease. Keeping up with the latest pharmacologic advances is crucial in providing the best possible care for your patients, and this book ensures that you are up to date with the latest information.

Managing comorbid diseases is a challenge for many healthcare professionals, but this book provides guidance on how to effectively manage these complex cases. The comprehensive information and insights provided will enable you to provide optimal care for your patients.

An exciting addition to this edition is the inclusion of global contributors, which provides international insights into cardiac drugs. This global perspective adds valuable depth and breadth to the book, ensuring that you are aware of the latest advancements from around the world.

To aid understanding, the book includes dynamic full-color drawings that visualize key pharmacologic and physiologic actions. These visuals help reinforce important concepts and make learning and reference easier.

In addition to the physical book, your purchase also grants you access to the complete contents online through Expert Consult. This online platform provides regular updates posted by leading cardiologist, Dr. Opie, ensuring that you have access to the most current information even after purchasing the book.

Ordering Drugs for the Heart is a must for any healthcare professional involved in the treatment of cardiovascular disease. Its comprehensive and up-to-date information, combined with its compact and portable format, make it an invaluable resource that will enhance your clinical practice.

Don’t miss out on the opportunity to have the latest information on cardiovascular drugs at your fingertips. Order your copy of Drugs for the Heart today and take your clinical decision-making to the next level.

Product Details

eBook Digital: 592 pages

Publisher: Saunders; 8th edition (February 6, 2013)

Language: English

ISBN-10: 1455733229

ISBN-13: 9781455733224

eText ISBN: 9781455726752

eText ISBN: 9788131238707

Your purchase entitles you to access the website until the next edition is published, or until the current edition is no longer offered for sale by Elsevier, whichever occurs first. In the event of the next edition being published within one year of your purchase, you will be entitled to online access for one year from the date of your purchase. Elsevier reserves the right to offer a suitable replacement product, such as a downloadable or CD-ROM-based electronic version, should access to the website be discontinued.